Clovis Oncology, Inc. (CLVS) Rockets on FDA Acceptance of New Drug Application

Shares of Boulder, Colorado, based Clovis Oncology, Inc. (CLVS) rose sharply on Tuesday, against the backdrop of slightly higher day in stocks overall. Clovis Oncology's stock was up 27.24%, rising $4.93 per share, to close at $23.03, on volume of 17,131,395 shares. The company announced that the Food and Drug Administration (FDA) has accepted its ... READ MORE Read the rest of Clovis Oncology, Inc. (CLVS) Rockets on FDA Acceptance of New Drug Application at InvestorGuide.com .